PolyPeptide slumps on FY miss

PolyPeptide AG

14/03/2023 08:19

** Shares in PolyPeptide Group  PPGN.S  slide around 11%
after the maker of peptides for pharma and biotech companies
published worse-than-expected FY results
    ** The company reports FY adj EBITDA decrease of 38.7
million euros ($41.4 million) vs 88.2 million euros year ago
with adj EBITDA margin of 13.8% vs 31.3% in 2021, reflecting
effects of increased cost base ahead of planned growth,
inflationary pressure and operational issues
    ** "FY22 numbers worse than expected," Baader Helvea says,
adding that the outlook is above expectations at the first
glance but highly backward loaded and therefore might be
questioned by the market
    ** Shares of PolyPeptide fell 9.8% in the last month​,
underperforming the STOXX index  .STOXX , which fell 4% 



($1 = 0.9350 euros)

 (Reporting by Anastasiia Kozlova)
 ((Anastasiia.Kozlova@thomsonreuters.com))